NCT02813967View on ClinicalTrials.gov

S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

298

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
Esophageal CancerChemoradiation
Interventions
RADIATION

Radiotherapy 54 Gy

Radiotherapy was administered in 1.8 Gy fractions 5 times weekly to a total dose of 54 Gy.

RADIATION

Radiotherapy 60 Gy

Radiotherapy was administered in 2 Gy fractions 5 times weekly to a total dose of 60Gy.

DRUG

S-1

S-1 70mg/m2 was administered on days 1-14 and 29-42.

Trial Locations (1)

310022

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors
lead

Zhejiang Cancer Hospital

OTHER

NCT02813967 - S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer | Biotech Hunter | Biotech Hunter